MIT’s Love Lab developing a Covid-19 vaccine to potentially reach billions
Manufacturability is key to producing a widely available, affordable vaccine.
Covid-19 calls MIT physician-scientist to front-line respiratory care
Neurologist and researcher Diane Chan pitches in to help New England get through tough times.
MIT team races to fill Covid-19-related ventilator shortage
An ad hoc team of engineers and doctors has developed a low-cost, open-source alternative, now ready for rapid production.
Proteins may halt the severe cytokine storms seen in Covid-19 patients
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections.
3 Questions: How Covid-19 tests work and why they’re in short supply
MIT scientists Omar Abudayyeh and Jonathan Gootenberg explain the current state of Covid-19 testing, and how a CRISPR tool may help solve the supply problem.
Gamma radiation found ineffective in sterilizing N95 masks
Nuclear scientists and biomedical researchers team up to investigate whether treatment with gamma radiation could make N95 masks more reusable.
!["Health care in [community health centers] has been turned upside down by the coronavirus pandemic," says Jeffrey Harris, physician and MIT economist. "Patients with chronic conditions are being dissuaded from coming in. Instead, telehealth service has become the new form of care."](/sites/default/files/styles/term_page__news_article/public/images/202004/Dr-Jeffrey-Harris-MIT.jpg?itok=FlFUHK4G)
3 Questions: Jeffrey Harris on the evolution of health care during the Covid-19 pandemic
Physician and MIT economist provides insights into health care during the pandemic, and how electronic or “telehealth” service has become the new form of care.
Accelerating data-driven discoveries
Life science companies use Paradigm4’s unique database management system to uncover new insights into human health.
“Living drug factories” might treat diabetes and other diseases
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
An experimental peptide could block Covid-19
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
MIT-based team works on rapid deployment of open-source, low-cost ventilator
Clinical and design considerations will be published online; goal is to support rapid scale-up of device production to alleviate hospital shortages.
MIT-affiliated companies take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
A stopgap measure to treat respiratory distress
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
Thank you for your patients
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
MIT community encouraged to respond to request for personal protective equipment
Area hospitals in need of PPE look to university labs and departments for donations.